Literature DB >> 15124871

Zygomycosis caused by Cunninghamella bertholletiae in a kidney transplant recipient.

D Quinio1, A Karam, J P Leroy, M C Moal, B Bourbigot, O Masure, B Sassolas, A M Le Flohic.   

Abstract

Infections caused by Cunninghamella bertholletiae are rare but severe. Only 32 cases have been reported as yet, but in 26 of these this species was a contributing cause of the death of the patient. This opportunistic mould in the order Mucorales infects immunocompromized patients suffering from haematological malignancies or diabetes mellitus, as well as solid organ transplant patients. The lung is the organ most often involved. Two cases of primary cutaneous infection have been previously reported subsequent to soft-tissue injuries. We report a case of primary cutaneous C. bertholletiae zygomycosis in a 54-year-old, insulin-dependent diabetic man who was treated with tacrolimus and steroids after kidney transplantation. No extracutaneous involvement was found. In this patient, the infection may have been related to insulin injections. The patient recovered after an early surgical excision of the lesion and daily administration of itraconazole for 2 months. This case emphasizes the importance of an early diagnosis of cutaneous zygomycosis, which often presents as necrotic-looking lesions. Prompt institution of antifungal therapy and rapid surgical intervention are necessary to improve the prospects of patients who have contracted these potentially severe infections.

Entities:  

Mesh:

Year:  2004        PMID: 15124871     DOI: 10.1080/13693780310001644644

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  9 in total

Review 1.  Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species.

Authors:  Marisa Z R Gomes; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

2.  Rhino-orbital-cerebral mucormycosis.

Authors:  Maria N Gamaletsou; Nikolaos V Sipsas; Emmanuel Roilides; Thomas J Walsh
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

Review 3.  Novel perspectives on mucormycosis: pathophysiology, presentation, and management.

Authors:  Brad Spellberg; John Edwards; Ashraf Ibrahim
Journal:  Clin Microbiol Rev       Date:  2005-07       Impact factor: 26.132

Review 4.  A case of Cunninghamella bertholettiae rhino-cerebral infection in a leukaemic patient and review of recent published studies.

Authors:  E Righi; C G Giacomazzi; V Lindstrom; A Albarello; O Soro; M Miglino; M Perotti; O E Varnier; M Gobbi; C Viscoli; M Bassetti
Journal:  Mycopathologia       Date:  2008-03-14       Impact factor: 2.574

5.  Skin mucormycosis presenting as an erythema-nodosum-like rash in a renal transplant recipient: a case report.

Authors:  Nader Nouri-Majalan; Mansour Moghimi
Journal:  J Med Case Rep       Date:  2008-04-19

Review 6.  Disseminated zygomycosis caused by Cunninghamella bertholletiae in patient with hematological malignancy and review of published case reports.

Authors:  Tsung-Ting Hsieh; Hsiang-Kuang Tseng; Pei-Lun Sun; Yu-Hung Wu; Gon-Shen Chen
Journal:  Mycopathologia       Date:  2012-11-04       Impact factor: 2.574

Review 7.  A Guide to Investigating Suspected Outbreaks of Mucormycosis in Healthcare.

Authors:  Kathleen P Hartnett; Brendan R Jackson; Kiran M Perkins; Janet Glowicz; Janna L Kerins; Stephanie R Black; Shawn R Lockhart; Bryan E Christensen; Karlyn D Beer
Journal:  J Fungi (Basel)       Date:  2019-07-24

Review 8.  Mucormycosis: A new threat to Coronavirus disease 2019 with special emphasis on India.

Authors:  Deganta Ghosh; Sagardeep Dey; Himanko Chakraborty; Sneha Mukherjee; Ankita Halder; Akash Sarkar; Pallab Chakraborty; Rajdeep Ghosh; Joy Sarkar
Journal:  Clin Epidemiol Glob Health       Date:  2022-03-19

9.  Severe falciparum malaria complicated by prolonged haemolysis and rhinomaxillary mucormycosis after parasite clearance: a case report.

Authors:  Katherine Plewes; Richard J Maude; Aniruddha Ghose; Arjen M Dondorp
Journal:  BMC Infect Dis       Date:  2015-12-03       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.